FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,820 | -43.5% | 2,600,000 | 0.0% | 0.88% | -39.8% |
| Q4 2022 | $26,234 | -100.0% | 2,600,000 | 0.0% | 1.46% | -41.1% |
| Q3 2022 | $58,266,000 | -9.6% | 2,600,000 | 0.0% | 2.49% | -27.7% |
| Q2 2022 | $64,428,000 | -16.9% | 2,600,000 | +30.0% | 3.44% | +6.0% |
| Q1 2022 | $77,540,000 | -26.4% | 2,000,000 | +11.1% | 3.25% | +13.6% |
| Q4 2021 | $105,318,000 | +22.5% | 1,800,000 | +24.1% | 2.86% | +48.6% |
| Q3 2021 | $85,942,000 | -26.6% | 1,450,000 | +7.4% | 1.92% | -19.1% |
| Q2 2021 | $117,167,000 | +9.3% | 1,350,000 | +3.8% | 2.38% | +25.6% |
| Q1 2021 | $107,185,000 | -15.8% | 1,300,000 | -7.1% | 1.89% | -30.7% |
| Q4 2020 | $127,302,000 | +112.3% | 1,400,000 | -6.7% | 2.73% | +87.8% |
| Q3 2020 | $59,955,000 | -2.9% | 1,500,000 | -16.7% | 1.46% | -15.8% |
| Q2 2020 | $61,758,000 | +32.4% | 1,800,000 | -14.3% | 1.73% | -12.3% |
| Q1 2020 | $46,641,000 | +8.3% | 2,100,000 | -4.5% | 1.97% | +18.5% |
| Q4 2019 | $43,054,000 | +38.6% | 2,200,000 | +10.0% | 1.66% | +33.6% |
| Q3 2019 | $31,060,000 | +2.0% | 2,000,000 | +33.3% | 1.24% | +1.1% |
| Q2 2019 | $30,450,000 | -3.7% | 1,500,000 | -16.7% | 1.23% | -4.6% |
| Q1 2019 | $31,626,000 | +14.6% | 1,800,000 | -16.3% | 1.29% | +26.3% |
| Q4 2018 | $27,585,000 | -22.7% | 2,150,000 | -1.8% | 1.02% | +10.1% |
| Q3 2018 | $35,675,000 | +85.1% | 2,190,000 | +28.8% | 0.93% | +126.3% |
| Q2 2018 | $19,278,000 | +132.4% | 1,700,000 | +100.0% | 0.41% | +294.2% |
| Q1 2018 | $8,296,000 | – | 850,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |